Senseonics Holdings, Inc. (NASDAQ: SENS) is a Healthcare company (Medical - Devices) with a market capitalization of $518M. The Maz Rating grades it against the other companies in its sector.
About three months ago (July 2, 2026), Senseonics Holdings, Inc. had a Maz Rating of 1.59 out of 5 (D, Sell), ranked against the other companies in its sector. Its strongest factor then was Growth (3.86), above most of its sector; its weakest was Financial Health (1.57), below most of its sector. The other factors: Valuation 2.57 (valued in line with its sector); Momentum 2.21 (below most of its sector); Profitability 2.04 (below most of its sector). The current rating is for members: log in to see it.
At $9.80, Senseonics Holdings, Inc. trades at 9.4x sales and 5.5x book value. Over the last twelve months it generated about $55M of revenue and a net loss of $137M. It runs a gross margin of 54.9%, an operating margin of -223.2% and a net margin of -225.3%. It shows return on equity of -165.8%, return on invested capital of -71.2% and a free cash flow yield of -21.3%. On the balance sheet: a debt-to-equity ratio of 0.68 and a current ratio of 6.74. Over the past 52 weeks the share price ranged from $4.79 to $10.64, with a beta of 1.04.
Senseonics Holdings, Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 9 Buy, 5 Hold and 3 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.